1. Celastrol Inhibits Lung Infiltration in Differential Syndrome Animal Models by Reducing TNF-α and ICAM-1 Levels while Preserving Differentiation in ATRA-Induced Acute Promyelocytic Leukemia Cells
   Li-min Xu et al, 2014, PLoS ONE CrossRef
2. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies
   Larisa Ryskalin et al, 2019, International Journal of Molecular Sciences CrossRef
3. Proteomic analysis of cell cycle arrest and differentiation induction caused by ATPR, a derivative of all‐trans retinoic acid, in human gastric cancer SGC‐7901 cells
   Quan Xia et al, 2017, PROTEOMICS – Clinical Applications CrossRef
4. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
   Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef
5. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma
   Meena Jhanwar-Uniyal et al, 2023, Advances in Biological Regulation CrossRef
6. Delineating the glioblastoma stemness by genes involved in cytoskeletal rearrangements and metabolic alterations
   Żaneta Kałuzińska-Kołat et al, 2023, World Journal of Stem Cells CrossRef
7. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma
   Marton Tompa et al, 2018, NeuroMolecular Medicine CrossRef
8. Discrete Mechanistic Target of Rapamycin Signaling Pathways, Stem Cells, and Therapeutic Targets
   Meena Jhanwar-Uniyal et al, 2024, Cells CrossRef
9. Nanomedicine: A Useful Tool against Glioma Stem Cells
   Elia Bozzato et al, 2020, Cancers CrossRef
10. Isolation and Characterization of Two Novel Colorectal Cancer Cell Lines, Containing a Subpopulation with Potential Stem-Like Properties: Treatment Options by MYC/NMYC Inhibition
    Jan Schulte am Esch et al, 2020, Cancers CrossRef
11. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells
    LIUQI YANG et al, 2014, Oncology Reports CrossRef
12. Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cells
    Yi-Peng Han et al, 2016, Neuro-Oncology CrossRef
13. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: A tale of two complexes
    Meena Jhanwar-Uniyal et al, 2015, Advances in Biological Regulation CrossRef
14. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
    Dana Hellmold et al, 2023, International Journal of Molecular Sciences CrossRef
15. Combination of chemotherapy and cancer stem cell targeting agents: Preclinical and clinical studies
    Yanyan Li et al, 2017, Cancer Letters CrossRef
16. Elucidating the Anti-Tumorigenic Efficacy of Oltipraz, a Dithiolethione, in Glioblastoma
    Upasana Kapoor-Narula et al, 2022, Cells CrossRef
17. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells
    Simona Daniele et al, 2015, Scientific Reports CrossRef
18. Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells
    Zhi-xiang Yuan et al, 2016, Frontiers in Pharmacology CrossRef
19. 4-Amino-2-trifluoromethyl-phenyl retinate induced differentiation of human myelodysplastic syndromes SKM-1 cell lines by up-regulating DDX23
    Cong Wang et al, 2020, Biomedicine & Pharmacotherapy CrossRef
20. Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression
    Krysta Mila Coyle et al, 2017, Scientific Reports CrossRef
21. HEB silencing induces anti-proliferative effects on U87MG cells cultured as neurospheres and monolayers
    Paulo R. D. V. Godoy et al, 2016, Molecular Medicine Reports CrossRef
22. Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells
    Michela Ferrucci et al, 2017, Oncotarget CrossRef
23. Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
    Pavel Pitule et al, 2014, BioMed Research International CrossRef
24. Enhanced expression of tumour suppressor RAR-β by DSPC nano-formulated lipo-ATRA in the lung of B16F10 cell-implanted C57BL6 mice and in A549 cells
    V.M. Berlin Grace et al, 2017, Life Sciences CrossRef
25. Biomarkers Regulated by Lipid-Soluble Vitamins in Glioblastoma
    Dina El-Rabie Osman et al, 2022, Nutrients CrossRef
26. mTORsignalling pathway in stem cell bioactivities and angiogenesis potential
    Hamid Lotfimehr et al, 2023, Cell Proliferation CrossRef
27. All‑trans retinoic acid therapy induces asymmetric division of glioma stem cells from the U87MG cell line
    Ruizhi Wang et al, 2019, Oncology Letters CrossRef
28. Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion
    Crescenzo D’Alterio et al, 2020, Seminars in Cancer Biology CrossRef
29. Cellular and molecular effects of the mTOR inhibitor everolimus
    Uttara Saran et al, 2015, Clinical Science CrossRef
30. Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
    Jianyang Du et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
31. Glioma stem cells and neural stem cells respond differently to BMP4 signaling
    Xin-Xin Han et al, 2022, Cell Regeneration CrossRef
32. Discrete signaling mechanisms of mTORC1 and mTORC2: Connected yet apart in cellular and molecular aspects
    Meena Jhanwar-Uniyal et al, 2017, Advances in Biological Regulation CrossRef
33. Quantitative Ultrastructural Morphometry and Gene Expression of mTOR-Related Mitochondriogenesis within Glioblastoma Cells
    Rosangela Ferese et al, 2020, International Journal of Molecular Sciences CrossRef
34. Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
    Meena Jhanwar-Uniyal et al, 2015, Cancers CrossRef
35. DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells
    Xiaojun Ding et al, 2017, Biochemical and Biophysical Research Communications CrossRef
36. Voxtalisib and low intensity pulsed ultrasound combinatorial effect on glioblastoma multiforme cancer stem cells via PI3K/AKT/mTOR
    Irmak Tutak et al, 2022, Pathology - Research and Practice CrossRef
37. Targeted therapy of cancer stem cells: inhibition of mTOR in pre-clinical and clinical research
    Boram Son et al, 2024, Cell Death & Disease CrossRef
38. Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer
    Massimo Moro et al, 2015, Journal of Thoracic Oncology CrossRef